Table of contents:
- Terms of Vaccines and Immunization
- Covid-19 Vaccine from the Government
- Process of Providing COVID-19 Vaccine from the Government
Providing a COVID-19 vaccine from the government is still one of the efforts to prevent and control the transmission of the COVID-19 disease. To find out what types of COVID-19 vaccines have been provided by the government, see the following article
Providing a COVID-19 vaccine from the government is the most effective solution to reduce the number of cases of infection with the SARS-CoV-2 virus that causes COVID-19.
The effectiveness and safety of the COVID-19 vaccine is still being researched by the government and various related institutions. This is a step to ensure that the COVID-19 vaccine provided is suitable for use to prevent COVID-19.
However, it should also be remembered that the COVID-19 prevention efforts must of course be accompanied by he alth protocols.
Terms of Vaccines and Immunization
Before getting to know more about the COVID-19 vaccine from the government, it helps us to know the difference between vaccines and immunizations.
Immunization is an effort to form or increase immunity, both adults and children, against a disease. One form of immunization is vaccination that aims to prevent certain diseases or avoid the risk of developing severe symptoms when suffering from a disease.
Vaccines usually contain microorganisms, such as dead or live but attenuated viruses or bacteria, which are useful for stimulating the immune system to recognize these microorganisms.
Covid-19 Vaccine from the Government
There are still many questions circulating about the effectiveness and side effects of the COVID-19 vaccine, both in Indonesia and around the world.To minimize possible side effects, the government continues to monitor all types of COVID-19 vaccines that will be given to the public.
Like other drugs and vaccines, the development of a COVID-19 vaccine must go through three stages of clinical trials and be declared effective and safe to use. After that, the COVID-19 vaccine can only get a distribution permit from the Food and Drug Supervisory Agency (BPOM).
Currently, in Indonesia there are several types of COVID-19 vaccines from the government which are being intensively given to the public, including:
This vaccination consists of three stages, namely the first, second, and third or booster doses of vaccine.
In addition to the several types of vaccines above, there are also other types of vaccines authorized by the Indonesian government, such as Novavax, Sputnik-V, Janssen, Convidencia, and Zifivax.
Process of Providing COVID-19 Vaccine from the Government
The government continues to strive to monitor and provide guidance, guidance, and facilities to support the development and acceleration of the government's provision of a COVID-19 vaccine for the community.
The following are some of the steps taken by the government to ensure the development and production of a COVID-19 vaccine from the government to run smoothly:
1. Supervision of vaccine distribution
One of the requirements in distributing vaccines is that the company that distributes vaccines must have 2 permits, namely a permit as a Pharmaceutical Wholesaler (PBF) issued by the Ministry of He alth and a distribution permit issued by BPOM.
There are 2 types of vaccine distribution management, namely vaccine distribution management at PBF and vaccine distribution management at pharmaceutical service facilities.
2. Vaccine quality control
Supervision of vaccine quality and safety is not only from the licensing process, but also vaccine control and management related to vaccine storage and delivery throughout Indonesia.
In order to maintain the quality and effectiveness, ideally the vaccine should be stored in a cold temperature, namely a refrigerator or ice box with a temperature of about 2–8oC or -15–5 oC.
The temperature where the vaccine is stored must also always be maintained during the process of storage, delivery, until when it is about to be given to the public.
3. Drug safety monitoring after marketing (pharmacovigilance)
After going through a series of rigorous clinical trial stages, from the production process to quality control along the distribution chain, the COVID-19 vaccine from the government will be circulated to the public.
Some people may experience side effects from the COVID-19 vaccine for a few days. This is normal and is a sign that the body is building up protection against the virus.
Therefore, the government continues to make various efforts to monitor and evaluate the safety of vaccines to ensure that they are suitable for use.
For those of you who have not received vaccinations, either the first, second, or booster vaccines, please come to the existing he alth care facilities, be it puskesmas, clinics, hospitals, or other he alth care units.
If you still have questions about the COVID-19 vaccine from the government, you can consult a doctor.